Capsular contracture is the abnormal tightening of the fibrous tissue capsule that forms around an implanted medical device. The term most commonly refers to a complication of breast implants used for cosmetic augmentation or breast reconstruction. Capsule formation is a normal response to an implant; contracture occurs when the capsule becomes abnormally firm and constricts the implant, potentially changing the breast’s shape, position, or feel and causing pain. It can affect one or both breasts and develop months or years after implantation.
Biological basis
An implant triggers a local foreign-body response involving the immune system, inflammation, and tissue repair. Cells deposit collagen around the implant, forming a capsule that separates it from surrounding tissue. A normal capsule is relatively thin and flexible.
In capsular contracture, excessive fibrosis, changes in collagen organization, and the activity of contractile cells called myofibroblasts contribute to capsule tightening. Capsule thickness alone does not fully explain the severity of symptoms or breast distortion.
The process is multifactorial. Persistent inflammation, bleeding around the implant, infection, and implant-related factors may contribute. Bacterial biofilms—communities of microorganisms attached to a surface—have been implicated in some cases, but their presence does not establish a single cause for all contractures.
Clinical features and classification
Features range from subtle firmness to a hard, visibly distorted breast. The implant may appear more rounded, sit higher than expected, or become less mobile. Discomfort can occur, although not every contracture is painful.
The Baker classification is widely used to describe clinical severity:
| Grade | Typical findings |
|---|---|
| I | The breast is soft and appears natural. |
| II | The breast is somewhat firm but appears normal. |
| III | The breast is firm and visibly abnormal. |
| IV | The breast is hard, painful, and visibly abnormal. |
Grade I describes a clinically normal result rather than clinically significant contracture. Grades III and IV are commonly used as endpoints for significant contracture in research. The classification is subjective, and agreement between examiners is imperfect. Modified grading systems are also used in reconstructive settings.
Frequency and associated factors
Reported rates vary substantially with the reason for implantation, implant characteristics, surgical technique, definition of contracture, and duration of follow-up. Rates measured after a short follow-up cannot be directly compared with cumulative rates measured over many years.
Contracture occurs after both silicone-gel and saline-filled implants. Associated factors include:
- Radiotherapy: Radiation therapy to the breast or chest wall is an important risk factor in implant-based reconstruction.
- Local complications: Bleeding, fluid collections, infection, and prolonged inflammation may contribute.
- Surgical setting: Primary augmentation, reconstruction after breast cancer, and revision procedures involve different tissues and risk profiles.
- Implant placement and surface: Position relative to the chest muscle and implant surface characteristics influence reported rates, although effects vary across clinical settings and studies.
Some studies have reported lower contracture rates with textured implants in particular settings. That finding cannot be considered independently of their association with breast implant–associated anaplastic large-cell lymphoma, a separate disease.
Diagnosis and differential diagnosis
Diagnosis is primarily clinical, based on symptoms, appearance, and physical examination. Assessment considers firmness, implant mobility, asymmetry, distortion, and tenderness.
Ultrasonography or magnetic resonance imaging may help evaluate implant integrity, surrounding fluid, or other abnormalities. Imaging complements rather than replaces clinical assessment.
The differential diagnosis includes implant displacement, rupture, infection, fluid collections, and other breast or implant-associated conditions. New swelling, a mass, or a delayed fluid collection is not specific to capsular contracture. Capsular contracture itself is not cancer, although it can coexist with other conditions.
Treatment and recurrence
Management varies with severity, symptoms, associated findings, and reconstructive circumstances. Mild firmness may be observed. Operations for more substantial contracture can include releasing the capsule, removing part or all of it, exchanging or removing the implant, or changing its position. These procedures fall within plastic surgery.
Capsulotomy means surgically opening or releasing the capsule; capsulectomy means removing capsule tissue. Complete capsule removal is not required in every case and can carry additional operative risks. “En bloc” removal is not synonymous with routine capsulectomy and is not a general requirement for uncomplicated contracture.
Nonsurgical approaches have been studied, but evidence for durable benefit is limited and inconsistent. Forceful external compression to rupture the capsule, historically called closed capsulotomy, carries risks including implant damage and is generally avoided.
Contracture can recur after treatment. Comparisons between preventive and corrective techniques are limited by differences in patient populations, surgical methods, grading systems, and follow-up duration. No intervention reliably eliminates the possibility of recurrence.